Show an ad over header. AMP

Fauci says despite COVID variants, vaccines will bring normality back

The COVID-19 variants first detected in the U.K. and South Africa and now circulating globally aren't a current threatto the effectiveness of the first vaccines, but mutations will be closely monitored because "they could be an issue," NIAID director Anthony Fauci tells Axios.

The big picture: Vaccinations are underway, albeit with a slow start. The get-back-to-normal-goal depends on reaching 70%–85% herd immunity in the population, Fauci says. While there are some concerns the mutations might circumvent the vaccines, he says they pose more of a problem for certain treatments than for vaccines.


What's happening: Viruses mutate frequently, but often those changes are small and don'tcause issues with treatments or vaccines. Public health officials have been tracking SARS-CoV-2 variants closely.

B.1.1.7 doesn't appear to be more virulent or to obviate the effect of the vaccine, based on what British doctors are saying, Fauci says.

  • B.1.1.7 is more transmissible because it binds more readily to the ACE2 receptor, which is how the virus enters cells.
  • That pushes the need for faster vaccinations, says Carlos del Rio, distinguished professor of medicine at Emory University School of Medicine.
  • "If the R-naught goes from 2.5 to 2.9 in a totally naive population, after 10 cycles of transmission, instead of 9,000 people infected, you have 42,000 people infected," del Rio warns.

The 501.V2 variant is "a little bit more concerning regarding the possibility of interfering with some of the monoclonal antibodies," based on preliminary findings, Fauci says.

  • Monoclonal antibody treatments precisely target one specific region of the virus and "if the mutation happens to be at that epitope, that could obviate the effect" of the treatment, he says.
  • Vaccines, on the other hand, "induce a polyclonal response against multiple different aspects of the spike protein," Fauci points out. "For something to really circumvent the efficacy of the vaccine, it's got to have a lot of mutations that are all at the right places."

What they're watching: Scientists are following the strains and testing them against the vaccines.

  • "If it doesn't impact the vaccine, you're good to go. If it does, you have to make some minor modifications of the vaccine to be able to circumvent the changes that occur in the mutations," Fauci says.
  • With the "plug-and-play" nature of the mRNA vaccines, it is much easier to alter the makeup of those vaccines, he adds.
  • And because there's now a large amount of data about the mRNA-based vaccine platform, "it is likely the FDA would consider it merely a strain change, which doesn't require starting from square one," he says.

The bottom line: "You always have to take these things seriously, follow them closely, and hope there will not be a problem. But, if there is, you have to adjust to it," Fauci says. "And now we have the technology to do that pretty easily."

Incoming White House plans extraordinary steps to protect Biden from COVID-19

The incoming administration is planning extraordinary steps to protect its most prized commodity, Joe Biden, including requiring daily employee COVID tests and N95 masks at all times, according to new guidance sent to some incoming employees Tuesday.

Why it matters: The president-elect is 78 years old and therefore a high risk for the virus and its worst effects, despite having received the vaccine. While President Trump's team was nonchalant about COVID protocols — leading to several super-spreader episodes — the new rules will apply to all White House aides in "high proximity to principals."

Keep reading... Show less

Justice Department drops insider trading inquiry against Sen. Richard Burr

The Department of Justice told Sen. Richard Burr (R-N.C.) on Tuesday that it will not move forward with insider trading charges against him.

Why it matters: The decision, first reported by the New York Times, effectively ends the DOJ's investigation into the senator's stock sell-off that occurred after multiple lawmakers were briefed about the coronavirus' potential economic toll. Burr subsequently stepped down as chair of the Senate Intelligence Committee.

Keep reading... Show less

Netflix tops 200 million global subscribers

Netflix said that it added another 8.5 million global subscribers last quarter, bringing its total number of paid subscribers globally to more than 200 million.

The big picture: Positive fourth quarter results show Netflix's resiliency, despite increased competition and pandemic-related production headwinds.

Keep reading... Show less

Biden's Treasury pick plays down debt, tax hikes during hearing

Janet Yellen, Biden's pick to lead the Treasury Department, pushed back against two key concerns from Republican senators at her confirmation hearing on Tuesday: the country's debt and the incoming administration's plans to eventually raise taxes.

Driving the news: Yellen — who's expected to win confirmation — said spending big now will prevent the U.S. from having to dig out of a deeper hole later. She also said the Biden administration's priority right now is coronavirus relief, not raising taxes.

Keep reading... Show less

Trump gives farewell address: "We did what we came here to do"

President Trump will give a farewell video address on Tuesday, saying that his administration "did what we came here to do – and so much more."

Why it matters: Via Axios' Alayna Treene, the address is very different from the Trump we've seen in his final weeks as president — one who has been refusing to accept his loss, who peddled conspiracy theories that fueled the attack on the Capitol, and who is boycotting his successor's inauguration. 

Keep reading... Show less

Europeans have high hopes for Joe Biden

Data: Pew Research Center; Chart: Andrew Witherspoon/Axios

Joe Biden's inauguration will be greeted with enthusiasm in Europe, with three new polls making clear that most Europeans can't wait to bid Donald Trump adieu.

The big picture: Europeans generally expect brighter days ahead under Biden, according to the polls, but his election has not fully assuaged doubts about U.S. democracy and global leadership.

Keep reading... Show less

U.S. surpasses 400,000 coronavirus deaths on Trump's final full day in office

Data: CSSE Johns Hopkins University; Chart: Andrew Witherspoon/Axios

Over 400,000 people have died from the coronavirus in the U.S. as of Tuesday, per Johns Hopkins data.

Why it matters: It only took a little over a month for the U.S. to reach this mass casualty after 300,000 COVID deaths were reported last month. That's over 100,000 fatalities in 36 days.

Keep reading... Show less

Special report: How U.S. policy toward China transformed under Trump

President Trump began his term by launching the trade war with China he had promised on the campaign trail. By mid-2020, however, Trump was no longer the public face of China policy-making as he became increasingly consumed with domestic troubles, giving his top aides carte blanche to pursue a cascade of tough-on-China policies.

Why it matters: Trump alone did not reshape the China relationship. But his trade war shattered global norms, paving the way for administration officials to pursue policies that just a few years earlier would have been unthinkable.

Keep reading... Show less

Insights

mail-copy

Get Goodhumans in your inbox

Most Read

More Stories